Disease Markers

Table of Contents: 2005

  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 381657

ɛ3ɛ4 Genotype as Risk Factor of Myocardial Infarction in Middle-Aged People in Spain

Carmen Garcés | Carolina Maicas | ... | Manuel de Oya
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 285134

Patterns of Global DNA and Histone Methylation Appear to be Similar in Normal, Dysplastic and Neoplastic Oral Epithelium of Humans

Chandrika J. Piyathilake | Walter C. Bell | ... | William E. Grizzle
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 684123

Estimation of Diabetes Risk in Brazilian Population by Typing for Polymorphisms in HLA-DR-DQ, INS and CTLA-4 Genes

Omar M. Hauache | André F. Reis | ... | Jorma Ilonen
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 693437

Salivary Thiobarbituric Acid Reacting Substances and Malondialdehyde – Their Relationship to Reported Smoking and to Parodontal Status Described by the Papillary bleeding index

Peter Celec | Július Hodosy | ... | Matúš Kúdela
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 487014

Polymorphisms in the Promoter Region of Catalase Gene and Essential Hypertension

Xiao Feng Zhou | Jing Cui | ... | Clinton T. Baldwin
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 251068

The Application of Plasma 1,5-Anhydro-D-glucitol for Monitoring Type 2 Diabetic Patients

Marzena Dworacka | Hanna Winiarska
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 370908

MUC Gene Abnormalities in Sporadic and Hereditary Mucinous Colon Cancers with Microsatellite Instability

Chiara Pastrello | Manuela Santarosa | ... | Alessandra Viel
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 218759
  • - Invited Paper

Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias

Georg Goebel | Marion Zitt | ... | Hannes M. Müller
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 318394
  • - Erratum

Endostatin Polymorphism 4349G/A(D104N) Is Not Associated with Aggressiveness of Disease in Prostate Cancer

He Cheng Li | Qiu Yin Cai | ... | Bo Lu
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 806573

Complement Protein Isoforms in CSF as Possible Biomarkers for Neurodegenerative Disease

Erin J. Finehout | Zsofia Franck | Kelvin H. Lee
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 848676

The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases

Pia Davidsson | Magnus Sjögren
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 864525
  • - Short Report

Two Polymorphisms in the Epithelial Cell-Derived Neutrophil-Activating Peptide (ENA-78) Gene

Mahsa M. Amoli | Bagher Larijani | ... | Miguel A. Gonzalez-Gay
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 381215

Age-Dependent Decrease in Serum Transforming Growth Factor (TGF)-Beta 1 in Healthy Japanese Individuals; Population Study of Serum TGF-Beta 1 Level in Japanese

Yoshihiro Okamoto | Yoshimitsu Gotoh | ... | Mikio Nishida
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 275318

Over-Expression of Dopamine D2 Receptor and Inwardly Rectifying Potassium Channel Genes in Drug-Naive Schizophrenic Peripheral Blood Lymphocytes as Potential Diagnostic Markers

Ágnes Zvara | György Szekeres | ... | László G. Puskás
  • Disease Markers -
  • Special Issue
  • Volume 21
  • - Article ID 340186

CYP1A1 Genetic Polymorphisms in Ecuador, South America

César Paz-y-Miño | Melissa Arévalo | ... | Paola. E. Leone
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.